alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 63, Number 143 (Monday, July 27, 1998)]
[Notices]
[Page 40100]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-19904]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

International Trade Administration


Cornell University; Notice of Decision on Application for Duty-
Free Entry of Scientific Instrument

    This decision is made pursuant to Section 6(c) of the Educational, 
Scientific, and Cultural Materials Importation Act of 1966 (Pub. L. 89-
651, 80 Stat. 897; 15 CFR part 301). Related records can be viewed 
between 8:30 AM and 5:00 PM in Room 4211, U.S. Department of Commerce, 
14th and Constitution Avenue, NW, Washington, DC.
    Docket Number: 98-028. Applicant: Cornell University, Ithaca, NY 
14853-1501. Instrument: Electron Microprobe, Model JXA-8900R. 
Manufacturer: Narishige Scientific, Japan. Intended Use: See notice at 
63 FR 31737, June 10, 1998.
    Comments: None received. Decision: Approved. No instrument of 
equivalent scientific value to the foreign instrument, for such 
purposes as it is intended to be used, is being manufactured in the 
United States. Reasons: The foreign instrument provides 
characterization of elemental composition and structure in surfaces 
with resolution down to 1 <greek-m>m. The National Institute of 
Standards and Technology advised July 26, 1996 that (1) this capability 
is pertinent to the applicant's intended purpose and (2) it knows of no 
domestic instrument or apparatus of equivalent scientific value to the 
foreign instrument for the applicant's intended use (comparable case).
    We know of no other instrument or apparatus of equivalent 
scientific value to the foreign instrument which is being manufactured 
in the United States.
Frank W. Creel,
Director, Statutory Import Programs Staff.
[FR Doc. 98-19904 Filed 7-24-98; 8:45 am]
BILLING CODE 3510-DS-P
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FINANCIAL
STATEMENTS OF FAIR GROUNDS CORPORATION FOR THE YEAR ENDED OCTOBER 31, 1999 AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          OCT-31-1999
<PERIOD-START>                             NOV-01-1998
<PERIOD-END>                               OCT-31-1999
<CASH>                                           8,614
<SECURITIES>                                         0
<RECEIVABLES>                                    1,079
<ALLOWANCES>                                         0
<INVENTORY>                                        125
<CURRENT-ASSETS>                                10,572
<PP&E>                                          55,993
<DEPRECIATION>                                  17,667
<TOTAL-ASSETS>                                  48,952
<CURRENT-LIABILITIES>                           10,719
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,525
<OTHER-SE>                                      27,090
<TOTAL-LIABILITY-AND-EQUITY>                    48,952
<SALES>                                         33,510
<TOTAL-REVENUES>                                41,795
<CGS>                                                0
<TOTAL-COSTS>                                   37,191
<OTHER-EXPENSES>                                 6,347
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  20
<INCOME-PRETAX>                                 (1,344)
<INCOME-TAX>                                      (236)
<INCOME-CONTINUING>                             (1,108)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                  2,518
<CHANGES>                                            0
<NET-INCOME>                                     1,410
<EPS-BASIC>                                       3.01
<EPS-DILUTED>                                     3.01


</TABLE>
Exhibit 32.1

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Donald C. Wood, the President and Chief Executive Officer of Federal Realty Investment Trust (the Company), has executed this certification in connection with the filing with the Securities and Exchange
Commission of the Companys Annual Report on Form 10-K/A for the period ended December 31, 2008 (the Report). The undersigned hereby certifies, to the best of his knowledge, that:



| | (1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|              |  |        |  |                                               
|------------- |  | ------ |  | ----------------------------------------------
|              |  |        |  | /s/ Donald C. Wood                            
|June 25, 2009 |  | NAME:  |  | Donald C. Wood                                
|              |  | TITLE: |  | President, Chief Executive Officer and Trustee
|              |  |        |  | (Principal Executive Officer)
Exhibit 10.10

Amendment to Employment Agreement with certain officers
-------------------------------------------------------


Mr. Martin Feinstein has amended his employment agreement with the Company as 
of June 15, 1998:

     WHEREAS, Farmers Group, Inc., a Nevada corporation, (the "Company") and 
Martin D. Feinstein (the "Executive") have entered into an employment 
agreement dated October 15, 1997 (the "Agreement").

     WHEREAS, it is the desire of the Company and the Executive to amend the 
Agreement in certain respects.

     NOW, THEREFORE, in consideration of the premises and respective covenants 
and agreements of the parties herein contained, and intending to be legally 
bound hereby, the parties hereto agree to additional provisions in the 
following sections.

     1.  Section 6(d) of the Agreement is hereby modified in its entirety to 
read as follows:

         (d)  Termination by the Executive.  The Executive may terminate his 
     employment hereunder for Good Reason.  For purposes of any determination 
     regarding the existence of Good Reason, any claim by the Executive that 
     Good Reason exists shall be presumed to be correct unless (except for 
     purposes of Subsection 13(h)(i)) the Company establishes to the then 
     existing Compensation Committee of the Board that Good Reason does not 
     exist.

     2.  The first paragraph of Section 13(h) of the Agreement is hereby 
modified in its entirety to read as follows:

         (h)  Good Reason.  The Executive's termination of employment with the 
     Company shall be deemed for "Good Reason" (i) if the Executive voluntarily
     resigns for any reason during the first eighteen (18) months following 
     the Merger or (ii) if, after such eighteen (18) month period the 
     Executive's termination occurs within twelve (12) months of any of the 
     following without the Executive's express written consent.

     3.  Subsections 13(h)(i) through (iv) of the Agreement are hereby 
redesignated as Subsections 13 (h)(ii)(A) through (F), respectively.

     4.  A new Section 13(i) of the Agreement is hereby created to read in 
its entirety as follows:

         (i)  Merger.  "Merger" shall mean the merger described in that 
     certain Agreement and Plan of Merger between B.A.T Industries, p.l.c. 
     and Zurich Insurance Company dated December 22, 1997. 

     5.  Subsections 13(i) through 13(k) of the Agreement are hereby 
redesignated as Subsections 13(j) through 13(l), respectively.


FARMERS GROUP, INC. a Nevada Corporation

By:      /s/  David P. Allvey                            Dated:  June 15, 1998
         -----------------------------------------------
Name:  David P. Allvey                                                     

Title: Director                                                          


Martin D. Feinstein

   /s/ Martin D. Feinstein                               Dated:  June 15, 1998
--------------------------------------------------------
               (signature)
No. 10-10640.

#### Leroy M., Petitioner v. City of New York, New York.

565 U.S. 842, 132 S. Ct. 155,

181 L. Ed. 2d 71,

2011 U.S. LEXIS 6344.

October 3, 2011.

Petition for writ of certiorari to the Court of Appeals of New York denied.

Same case below, 16 N.Y.3d 243, 919 N.Y.S.2d 484, 944 N.E.2d 1123.
# In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

No. 13

- 531 V

Filed: October 3, 2014

Not for P ublication

*************************************

BETTINE DELEA

, *

*

Petitioner

, *

*

* Damages decision based on stipulation;

v. * influenza (flu) vaccine; Guillain

- Barré

* Syndrome (GBS)

SECRETARY OF HEALTH *

AND HUMAN SERVICES, *

*

Respondent. *

*

*************************************

Ronald C. Homer

, Boston, MA

, for petitioner

. Glenn A. MacLeod , Washington, DC, for respondent.

MILLMAN, Special Master

DECISION AWARDING DAMAGES 1

On Octo ber 3 , 2014 , the parties filed the attached stipulation in which they agreed to settle

this case and described the settlement terms. Petitioner allege s that she suffered Guillain

- Barré

Syndrome (“GBS”) that w as caused by her September 14, 2010

, receipt of influenza (“flu ”)

vaccine

. Petitioner further allege s that she suffe r ed the residual effects of this injury for more

than six months. Respondent denies that the flu vaccine caused petitioner’s alleged GBS or any

other injury and further denies that her current disabilities are a sequela of a vaccine

- rel ated injury

.

1 Because this unpublished decision contains a reasoned exp lanation for the special master’ s action in this

case, the special master intends to post this unpublished decision on the United States Court of Federal

Claims’ s website, in accordance with the E

- Government Act of 2002, Pub. L. No. 107

- 347, 116 Stat. 2899,

2913 (Dec. 17, 2002). Vaccine Rule 18(b) states that all decisions of the special masters will be made

available to the public unless they contain trade secrets or commercial or financial information that is

privileged and confidential, or medical or similar information whose disclosure would constitute a clearly

unwarranted invasion of privacy. When such a decision is filed, petitioner has 14 days to identify a nd

move to delete such information prior to the document ’ s disclosure. If the special master, upon review,

agrees that the identified material fits within the banned categories listed above, the special master shall

delete such material from public access

.2

Nonetheless, the parties agreed to resolve this matter informally

.

The undersigned finds the terms of the stipulation to be reasonable. The court hereby

adopts the parties ’ said stipulation, attached her eto, and awards compensation in the amount and

o n the terms set forth therein. Pursuant to the stipulation, the court awards a lump sum of

$ 14 5 ,000.00

, representing reimbursement for all damages that would be available under 42 U.S.C.

§ 300aa

- 15(a) (2006). The award shall be in the form of a check payable to petitioner in the

amount of $ 145 ,000.00.

In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the

court is directed to enter judgment herewith. 2

IT IS SO ORDERED.

Dated: October 3, 2014 s/ Laura D. Millman

Laura D. Millman

Special Master

2 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party , either separately or

jointly, filing a notice renouncing the right to seek review.
Exhibit 32.2



STATEMENT OF CHIEF FINANCIAL OFFICER UNDER 18 U.S.C. § 1350



I, Eric Smit, the chief financial officer of eGain Communications Corporation
(the Company), certify for the purposes of section 1350 of chapter 63 of title 18 of the United States Code that, to my knowledge,



(i) the Quarterly Report of the Company on Form 10-Q for the period ending September 30, 2004 (the Report), fully complies with the
requirements of section 13(a) of the Securities Exchange Act of 1934, and



(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/ ERIC N. SMITEric N. SmitNovember 15, 2004




A signed original of this
written statement required by 18 U.S.C. § 1350 has been provided to eGain Communications Corporation and will be retained by eGain Communications Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

---

|1 | The material contained in this Exhibit 32.2 is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of
the company under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after date hereof and irrespective of any general incorporation language contained in such filing.
|- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
[Federal Register Volume 63, Number 142 (Friday, July 24, 1998)]
[Notices]
[Pages 39870-39871]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-19830]


-----------------------------------------------------------------------

FEDERAL EMERGENCY MANAGEMENT AGENCY

[FEMA-1233-DR]


New York; Amendment No. 2 to Notice of a Major Disaster 
Declaration

AGENCY: Federal Emergency Management Agency (FEMA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice amends the notice of a major disaster for the 
State of New York (FEMA-1233-DR), dated July 7, 1998, and related 
determinations.

EFFECTIVE DATE: July 14, 1998.

FOR FURTHER INFORMATION CONTACT: Madge Dale, Response and Recovery 
Directorate, Federal Emergency Management Agency, Washington, DC 20472, 
(202) 646-3260.

SUPPLEMENTARY INFORMATION: The notice of a major disaster for the State 
of New

[[Page 39871]]

York, is hereby amended to include the Hazard Mitigation Grant Program 
among those areas determined to have been adversely affected by the 
catastrophe declared a major disaster by the President in his 
declaration of July 7, 1998:

    All counties in the State of New York are eligible to apply for 
assistance under the Hazard Mitigation Grant Program.

(The following Catalog of Federal Domestic Assistance Numbers (CFDA) 
are to be used for reporting and drawing funds: 83.537, Community 
Disaster Loans; 83.538, Cora Brown Fund Program; 83.539, Crisis 
Counseling; 83.540, Disaster Legal Services Program; 83.541, 
Disaster Unemployment Assistance (DUA); 83.542, Fire Suppression 
Assistance; 83.543, Individual and Family Grant (IFG) Program; 
83.544, Public Assistance Grants; 83.545, Disaster Housing Program; 
83.548, Hazard Mitigation Grant Program)
Laurence W. Zensinger,
Division Director, Response and Recovery Directorate.
[FR Doc. 98-19830 Filed 7-23-98; 8:45 am]
BILLING CODE 6718-02-P
Exhibit 32.1

CERTIFICATION

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United
States Code), the undersigned officer of Heidrick & Struggles International, Inc., a Delaware corporation (the Company), does hereby certify that:

The Quarterly Report on Form 10-Q for the quarter ended June 30, 2008 (the Form 10-Q) of the Company fully complies with the requirements of section 13 (a) or 15 (d) of the Securities
Exchange Act of 1934 and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                      |  |                        
|--------------------- |  | -----------------------
|Dated: August 6, 2008 |  | /s/ L. Kevin Kelly     
|                      |  | L. Kevin Kelly         
|                      |  | Chief Executive Officer
DLA FORM 1900, MAY 2008 PDF (DLA)

TASK TRAINING AND CERTIFICATION RECORD

Page # of ##

TRAINEE NAME FOR TASKS COMPLETED BETWEEN

CRITICAL TASK

TASK NUMBER

TASKS, KNOWLEDGE 

& TECHNICAL REFERENCES

CERTIFICATION

START DATE

DATE 

COMPLETED

TRAINEE'S 

INITIALS

CERTIFIER'S 

INITIALS 

TRAINER'S 

(If Required)

INITIALS
<PAGE> 1

                                                                     EXHIBIT 11
                                                                     ----------

<TABLE>
                                Falcon Products, Inc. and Subsidiaries

                                  COMPUTATION OF EARNINGS PER SHARE
                                  ---------------------------------

              For the years ended November 1, 1997, November 2, 1996 and October 28, 1995
<CAPTION>
(In thousands, except per share amounts)
                                                                 1997<F1>          1996<F1>         1995<F1>
                                                                 --------          --------         --------
<S>                                                              <C>                <C>              <C>
Primary Earnings Per Share:
---------------------------

Average number of common shares outstanding                        9,665             9,591            9,497

Assumed exercise of options (treasury stock method)                  176               202              247
                                                                 -------            ------           ------

Shares for primary computation                                     9,841             9,793            9,744
                                                                 =======            ======           ======

Net earnings                                                     $12,634            $8,433           $7,457
                                                                 =======            ======           ======

Primary earnings per share                                       $  1.28            $  .86           $  .77
                                                                 =======            ======           ======

Fully Diluted Earnings Per Share
--------------------------------

Average number of common shares outstanding                        9,691             9,657            9,497

Assumed exercise of options (treasury stock method)                  211               202              302
                                                                 -------            ------           ------

Shares for fully diluted computation                               9,902             9,859            9,799
                                                                 =======            ======           ======

Net earnings                                                     $12,634            $8,433           $7,457
                                                                 =======            ======           ======

Fully diluted earnings per share                                 $  1.28            $  .86           $  .76
                                                                 =======            ======           ======

<FN>
<F1>Per share data reflects adjustments related to December 1995, 10% stock dividend.
</TABLE>
<PAGE>


               CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Lodgian, Inc., (the "Company") on
Form 10-Q for the period ended September 30, 2002 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Richard Cartoon,
the Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that, to the
best of my knowledge and after reasonable inquiry:

         3.       The Report fully complies with the requirements of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         4.       The information contained in the Report fairly presents, in
                  all material respects, the financial condition and results of
                  operations of the Company.


                                               LODGIAN, INC.

                                      By:    /s/  RICHARD CARTOON
                                     -----------------------------------
                                               RICHARD CARTOON
                                         Executive Vice President and
                                          Chief Financial Officer



                                       41
##### 



EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18
U.S.C. SECTION 1350 BY THE CHIEF EXECUTIVE OFFICER
RELATING TO A PERIODIC REPORT CONTAINING FINANCIAL STATEMENTS

I, Roger S. Newton, Chief Executive Officer, of Esperion Therapeutics,
Inc., a Delaware corporation (the Company), hereby certify that:

(1)  The Companys periodic report on Form 10-Q for the period ended June 30,
2003 (the Form 10-Q) fully complies with the requirements of Section 13(a) of
the Securities Exchange Act of 1934, as amended; and

(2)  The information contained in the Form 10-Q fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

* * *



|                                                              |  | 
|------------------------------------------------------------- |  | 
|                                                              |  | 
|/s/ Roger S. Newton

Roger S. Newton,
Chief Executive Officer |  | 

Date: August 14, 2003
May 27, 2015

**MEETING ON 1,4 -**  **DIOXANE PROBLEM FORMULATION AND INITIAL ASSESSMENT** EPA OCSPP/OPPT RISK ASSESSMENT DIVISION

**PURPOSE:** Meeting of industry representatives with EPA to discuss the 1,4
- Dioxane Problem Formulation and Initial Assessment
.
**ATTENDEES:** EPA/OCSPP/OPPT/RAD Tala Henry Stanley Barone Yvette Selby
- Mohamadu Susan Laessig Scott Prothero Charles Bevington
INDUSTRY ATTENDING IN PERSON Christina Franz, ACC Sarah Brozena, ACC Paul DeLeo, American Cleaning Institute (ACI) Steve Bennett, Consumer Specialty Products Association (CSPA) Stephen Wieroniey and Javaneh Nekoomaram, American Coatings Association (ACA) Kerry Kelly, Waste Management Mark Collatz, Adhesive and Sealant Council (ASC)
INDUSTRY ATTENDING ON PHONE Shaun Clancy, Evonik Ju lie Froehlicher, Proctor & Gamble Connie Deford, Dow Chemical Jeff Brown, BASF Sangeeta Khattar, BASF Iain Davies, Personal Care Products Council (PCPC)
**DoD 4000.25-1-M**

**DoD 4000.25-1-M,***April 28, 2004*

*DLM 4000.25, Volume 2, November 26, 2019*

*Change 13*

**AP8.44. APPENDIX 8.44**

**FOLLOW-UP FOR MATERIEL RETURNS PROGRAM CREDIT**

(See DLM 4000.25 Volume 4 (MILSBILLS), Appendix 3)

1

APPENDIX 3.44

AP8.44-1

APPENDIX 8.44